Canine leptospirosis: A re-emerging disease in the United States (Proceedings) - Veterinary Healthcare
  • SEARCH:

ADVERTISEMENT

Canine leptospirosis: A re-emerging disease in the United States (Proceedings)


CVC IN KANSAS CITY PROCEEDINGS


References

1. Ward MP, Glickman LT, Guptill L. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). JAVMA. 2002;220:53-58.

2. Ward MP, Guptill LF, Prahl A, Wu C-C. Serovar-specific prevalence and risk factors for leptospirosis among dogs: 90 cases (1997-2002). JAVMA. 2004;224:1958-1963.

3. Harkin KR, Gartrell CL. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990-1995). JAAHA. 1996;32:495-501.

4. Birnbaum N, Barr SC, Center SA, Schermerhorn T, Randolph JF, Simpson KW. Naturally acquired leptospirosis in 36 dogs: serological and clinicopathological features. J Small Anim Pract. 1998;39:231-236.

5. Adin CA, Cowgill LD. Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). JAVMA. 2000;216:371-375.

6. Stokes JE, Kaneene JB, Schall WD, et al. Prevalence of serum antibodies against six Leptospira serovars in healthy dogs. JAVMA. 2007;230:1657-1664.

7. Prescott JF, McEwen B, Taylor J, Wookds JP, Abrams-Ogg A, Wilcock B. Resurgence of leptospirosis in dogs in Ontario: recent findings. Can Vet J. 2002;43:955-961.

8. Moore GE, Guptill LF, Glickman NW, Caldanaro RJ, Aucoin D, Glickman LT. Canine leptospirosis, United States, 2002-2004. Emerg Infect Dis. 2006;12:501-503.

9. Sessions JK, Greene CE. Canine leptospirosis: Epidemiology, pathogenesis, and diagnosis. Compend Contin Educ Pract Vet. 2004;26:606-623.

10. Langston CE, Heuter KJ. Leptospirosis— A re-emerging zoonotic disease. Vet Clin North Am Small Anim Pract. 2003;33:791-807.

11. Ward MP. Seasonality of canine leptospirosis in the United States and Canada and its association with rainfall. Prev Vet Med. 2002;56:203-213.

12. Kim HW, Chew BP, Wong TS, et al. Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol. 2000;74:315-327.

13. Ghneim GS, Viers JH, Chomel BB, Kass PH, Descollongs DA, Johnson ML. Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet Res. 2007;38:37-50.

14. Ward MP, Guptill LF, Wu C-C. Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases (1997-2002). JAVMA. 2004;225:72-77.

15. Goldstein RE, Lin RC, Langston CE, Scrivani PV, Erb HA, Barr SC. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J Vet Intern Med. 2006;20:489-494.

16. Wohl JS. Canine leptospirosis. Compend Contin Educ Pract Vet. 1996;18:1215-1225.

17. Bolin CA. Diagnosis of leptospirosis: A reemerging disease of companion animals. Semin Vet Med Surg. 1996;11:166-171.

18. Ribotta MJ, Fortin M, Higgins R. Canine leptospirosis: Serology. Can Vet J. 2000;41:494-495.

19. Harkin KR, Roshto YM, Sullivan JT. Clinical application of a polymerase chain reaction assay for diagnosis of leptospirosis in dogs. JAVMA. 2003;222:1224-1229.

20. Sessions JK, Greene C. Canine leptospirosis: treatment, prevention, and zoonosis. Comp Contin Educ Pract Vet. 2004;26:700-706.

21. Truccolo J, Charavay F, Merien F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 2002;46:848-853.

22. Barr SC, McDonough PL, Scipioni-Ball RL, Starr JK. Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschneria serovar grippotyphosa. Am J Vet Res. 2005;66:1780-1784.

23. Brown K, Prescott JF. Leptospirosis in the family dog: a public health perspective. CMAJ. 2008;178:397-398.


ADVERTISEMENT

Source: CVC IN KANSAS CITY PROCEEDINGS,
Click here